Cost Effectiveness if Primary PCI Versus Thrombolytic Therapy in Acute STEMI in Assiut University Hospital

• Conditions: ST Elevation Myocardial Infarction

• Registration Number: NCT03310437
• Lead Sponsor: Nahed Sameh Zaki

Brief Summary

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients without contraindications

Detailed Description

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients 100 patient each within 90 m for PPCI and 6h for thrombolytic

Study Timeline

• Study First Submitted: 2017-09-25
• Study First Submitted QC: 2017-10-10
• Study First Posted: 2017-10-16
• Study Start: 2018-02-07
• Status Verified: 2019-07
• Last Update Submitted: 2019-07-01
• Last Update Posted: 2019-07-05
• Primary Completion: 2020-04-01
• Study Completion: 2020-10-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• All PPCI patients within 90 minutes door to ballon.
• All thrombolytic patient without contraindication ,within 6 golden hours of chest pain.

Exclusion Criteria

• patients don't meet inclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compare between PPCI and thrombolytic therapy regarding over all cost in STEMI patients	one year for collecting 100 patient for each arm with follow up 6 month	we will compare different outcomes in ST elevation myocardial infarction patients presented to our hospital who had recieved intervention (primary PCI ) versus thrombolytic as regarded in all over cost in egyptian pounds and follow up for 6 month

Trial Locations

Locations (1)

Assiut medicine faculty; 🇪🇬 Assiut, Egypt